PMGC HOLDINGS INC. Capital Expenditures
PMGC HOLDINGS INC. (ELAB) reported Capital Expenditures of $335.52 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-14
- PMGC HOLDINGS INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was -$27.57K.
- PMGC HOLDINGS INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $363.09K.
- PMGC HOLDINGS INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $346.66K.
- PMGC HOLDINGS INC. payments to acquire property, plant, and equipment for the quarter ending 2024-12-31 was $0.00.
- PMGC HOLDINGS INC. payments to acquire property, plant, and equipment for fiscal 2025 was $442.25K, a 4728.11% increase from fiscal 2024.
- PMGC HOLDINGS INC. payments to acquire property, plant, and equipment for fiscal 2024 was $9.16K, a 18.15% decline from fiscal 2023.
- PMGC HOLDINGS INC. payments to acquire property, plant, and equipment for fiscal 2023 was $11.19K.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$27.57K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $335.52K 10-Q · filed 2026-08-14 | $682.18K derived: sum of 3 quarters · filed 2026-08-14 | |
| 2026-03-31 | $363.09K 10-Q · filed 2026-05-15 | $709.75K derived: sum of 2 quarters · filed 2026-05-15 | ||
| 2025-12-31 | $346.66K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $442.25K 10-K · filed 2026-03-30 | ||
| 2025-09-30 | $95.59K 10-Q · filed 2025-11-14 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | $0.00 derived: sum of 3 quarters · filed 2026-03-30 | $9.16K 10-K · filed 2026-03-30 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2025-11-14 | $9.16K 10-Q · filed 2025-11-14 | $9.16K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $9.16K 10-Q · filed 2025-08-13 | $9.16K derived: sum of 3 quarters · filed 2025-08-13 | $9.16K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $9.16K 10-Q · filed 2025-05-14 | $9.16K derived: sum of 2 quarters · filed 2025-05-14 | $9.16K derived: sum of 3 quarters · filed 2025-05-14 | $9.16K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $0.00 derived: sum of 2 quarters · filed 2025-03-28 | $0.00 derived: sum of 3 quarters · filed 2025-03-28 | $11.19K 10-K · filed 2025-03-28 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $11.19K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $11.19K 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | $11.19K 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |